PMID- 30761780 OWN - NLM STAT- MEDLINE DCOM- 20190829 LR - 20190829 IS - 1097-0339 (Electronic) IS - 1097-0339 (Linking) VI - 47 IP - 6 DP - 2019 Jun TI - Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia. PG - 553-563 LID - 10.1002/dc.24155 [doi] AB - BACKGROUND: Lobular endocervical glandular hyperplasia (LEGH) was first described by Nucci et al. in 1999 and is believed to be a precancerous lesion of minimal deviation adenocarcinoma and gastric-type adenocarcinoma in the uterine cervix. LEGH lesions do not always exhibit apparent cellular and structural atypia, so are difficult to distinguish from normal endocervical cells (EC cells) with cytological examination. Therefore, we often struggle to make a definite diagnosis of LEGH. METHODS: We used microscopy images of cytological specimens that were diagnosed as EC cells and LEGH cells. Signal intensity in whole nuclear area and in heterochromatin and euchromatin regions, euchromatin area ratio, and nuclear morphological features were quantified in each cell nucleus of the cases. Statistical analyses were conducted to determine statistical significance. Finally, we performed linear support vector machine (LSVM) modeling as a discriminant analysis using the quantified features. RESULTS: Signal intensity in whole nuclear area, and heterochromatin and euchromatin regions of EC cell nuclei were higher than that of the LEGH cell nuclei. Morphologically, EC cell nuclei were larger than LEGH cell nuclei, and nuclei of LEGH cells had irregular nuclear respectively membrane structure and an elongated shape. The LSVM accuracy of 10-fold cross validation and leave-one-case-out cross-validation (LOCOCV) using all measured features were 84.7% to 89.3% and 78.6% to 86.0%, respectively. CONCLUSIONS: The LVSM analysis using features extracted from signal intensity and morphological analysis was useful for discrimination of EC cells vs LEGH cells. We therefore believe that this image analysis method could be used for early detection of LEGH. CI - (c) 2019 Wiley Periodicals, Inc. FAU - Kimura, Fumikazu AU - Kimura F AUID- ORCID: 0000-0001-7269-2497 AD - Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University. FAU - Kobayashi, Takaki AU - Kobayashi T AD - Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University. FAU - Kanai, Ryo AU - Kanai R AD - Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University. FAU - Kobayashi, Yukihiro AU - Kobayashi Y AD - Department of Laboratory Medicine, Shinshu University Hospital. FAU - Yuhi, Ohtani AU - Yuhi O AD - Department of Information Processing, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology. FAU - Ota, Hiroyoshi AU - Ota H AD - Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University. FAU - Yamaguchi, Masahiro AU - Yamaguchi M AD - Department of Information Processing, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology. FAU - Yokokawa, Yoshiharu AU - Yokokawa Y AD - Division of Physical Therapy, Shinshu University School of Health Sciences. FAU - Uehara, Takeshi AU - Uehara T AD - Department of Laboratory Medicine, Shinshu University School of Medicine. FAU - Ishii, Keiko AU - Ishii K AD - Division of Diagnostic Pathology, Okaya City Hospital. LA - eng PT - Journal Article DEP - 20190213 PL - United States TA - Diagn Cytopathol JT - Diagnostic cytopathology JID - 8506895 RN - 0 (Euchromatin) RN - 0 (Heterochromatin) SB - IM MH - Cell Nucleus/pathology MH - Diagnosis, Differential MH - Euchromatin/*chemistry MH - Female MH - Heterochromatin/*chemistry MH - Humans MH - Hyperplasia MH - *Image Processing, Computer-Assisted MH - Reproducibility of Results MH - Uterine Cervical Neoplasms/*diagnosis/*pathology OTO - NOTNLM OT - euchromatin OT - heterochromatin OT - linear support vector machine OT - lobular endocervical glandular hyperplasia OT - signal intensity EDAT- 2019/02/15 06:00 MHDA- 2019/08/30 06:00 CRDT- 2019/02/15 06:00 PHST- 2018/09/07 00:00 [received] PHST- 2019/01/18 00:00 [revised] PHST- 2019/01/22 00:00 [accepted] PHST- 2019/02/15 06:00 [pubmed] PHST- 2019/08/30 06:00 [medline] PHST- 2019/02/15 06:00 [entrez] AID - 10.1002/dc.24155 [doi] PST - ppublish SO - Diagn Cytopathol. 2019 Jun;47(6):553-563. doi: 10.1002/dc.24155. Epub 2019 Feb 13.